VOYA Investment Management
RYTM icon

VOYA Investment Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

VOYA Investment Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.3M Buy
272,974
+39,164
+17% +$3.54M 0.03% 419
2026
Q1 		$20.3M Sell
233,810
-16,064
-6% -$1.56M 0.02% 469
2025
Q4 		$26.7M Buy
249,874
+28,281
+13% +$3M 0.03% 441
2025
Q3 		$22.4M Sell
221,593
-22,410
-9% -$2.08M 0.02% 467
2025
Q2 		$15.4M Buy
244,003
+158,154
+184% +$9.68M 0.02% 606
2025
Q1 		$4.55M Sell
85,849
-11,320
-12% -$628K 0.01% 1006
2024
Q4 		$5.44M Sell
97,169
-5,663
-6% -$313K 0.01% 946
2024
Q3 		$5.39M Buy
102,832
+65,021
+172% +$3.12M 0.01% 973
2024
Q2 		$1.55M Sell
37,811
-134,941
-78% -$5.39M ﹤0.01% 1405
2024
Q1 		$7.49M Buy
172,752
+107,761
+166% +$4.72M 0.01% 847
2023
Q4 		$2.99M Sell
64,991
-19,268
-23% -$608K ﹤0.01% 1204
2023
Q3 		$1.93M Buy
84,259
+221
+0.3% +$4.95K ﹤0.01% 1340
2023
Q2 		$1.39M Buy
84,038
+20,443
+32% +$369K ﹤0.01% 1505
2023
Q1 		$1.13M Hold
63,595
– – ﹤0.01% 1586
2022
Q4 		$1.85M Hold
63,595
– – ﹤0.01% 1365
2022
Q3 		$1.56M Buy
+63,595
New +$1.18M ﹤0.01% 1430
2022
Q2 		– Sell
-17,216
Closed -$198K – 2876
2022
Q1 		$198K Hold
17,216
– – ﹤0.01% 2373
2021
Q4 		$172K Sell
17,216
-43
-0.2% -$483 ﹤0.01% 2559
2021
Q3 		$225K Hold
17,259
– – ﹤0.01% 2499
2021
Q2 		$338K Buy
17,259
+1,228
+8% +$25.5K ﹤0.01% 2320
2021
Q1 		$341K Buy
16,031
+1,265
+9% +$36.7K ﹤0.01% 2255
2020
Q4 		$439K Buy
14,766
+2,640
+22% +$67.1K ﹤0.01% 1994
2020
Q3 		$263K Hold
12,126
– – ﹤0.01% 2016
2020
Q2 		$270K Sell
12,126
-2,670
-18% -$52K ﹤0.01% 2016
2020
Q1 		$225K Buy
14,796
+846
+6% +$15.1K ﹤0.01% 2066
2019
Q4 		$320K Buy
+13,950
New +$310K ﹤0.01% 2140

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VOYA Investment Management's RYTM Position: Q2 2026 in Review

VOYA Investment Management increased its Rhythm Pharmaceuticals (RYTM) stake by 17% in Q2 2026, buying an estimated $3.54M and bringing the position to 272,974 shares worth $30.3M. The position accounts for 0.03% of the portfolio, ranked #419.

VOYA Investment Management first reported a position in RYTM in Q4 2019 and has held it in 26 quarters since. 304 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • VOYA Investment Management held 272,974 shares of Rhythm Pharmaceuticals worth $30.3M as of Q2 2026.
  • VOYA Investment Management bought 39,164 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $3.54M.
  • Rhythm Pharmaceuticals made up 0.03% of VOYA Investment Management's portfolio in Q2 2026, its #419 holding.
  • VOYA Investment Management first reported a position in Rhythm Pharmaceuticals in Q4 2019 and has held it in 26 quarters since.
  • 304 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.